— Know what they know.
Not Investment Advice

ATNX NASDAQ

Athenex, Inc.
1W: -42.1% 1M: -82.5% 3M: -92.8% 1Y: -97.9% 3Y: -99.9% 5Y: -99.9%
$0.20
Last traded 2023-05-24 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $2.3M mcap · 7M float · 3.93% daily turnover

Balance Sheet Trends

Total Assets
$204M -23.7% ▼
5Y CAGR: +7.8%
Total Liabilities
$204M -28.2% ▼
5Y CAGR: +32.6%
Shareholders Equity
-$7M +99.3% ▲
Cash & Investments
$37M -40.7% ▼
5Y CAGR: -6.4%
Total Debt
$42M -71.8% ▼
5Y CAGR: +84.5%
Net Debt
$7M -93.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$50M$128M$86M$52M$36M
Short-Term Investments$58M$33M$139M$10M$1M
Cash & ST Investments$107M$161M$225M$62M$37M
Net Receivables$13M$17M$24M$27M$28M
Inventory$29M$33M$29M$35M$43M
Other Current Assets$22M$21M$15M-$61M$11M
Total Current Assets$171M$231M$292M$62M$125M
Property, Plant & Equip.$11M$32M$42M$34M$6M
Goodwill & Intangibles$48M$47M$49M$72M$72M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$950K-$106M$971K
Total Non-Current Assets$60M$79M$92M$134M$79M
Total Assets$231M$310M$384M$267M$204M
— Liabilities —
Accounts Payable$13M$23M$19M$17M$34M
Short-Term Debt$961K$4M$5M$50M$39M
Deferred Revenue$190K$218K$1M$3M$3M
Other Current Liabilities$38M$44M$37M$26M$39M
Total Current Liabilities$52M$72M$62M$96M$115M
Long-Term Debt$46M$60M$153M$150M$3M
Other Non-Current Liab.$5M$3M$4M$27M$108M
Total Non-Current Liabilities$51M$63M$157M$150M$113M
Total Liabilities$102M$310M$384M$284M$204M
— Equity —
Common Stock$69K$83K$95K$111K$9K
Retained Earnings-$444M-$567M-$714M-$913M-$1.0B
Accumulated OCI-$656K-$635K-$1M-$487K$887K
Total Stockholders Equity$139M$188M$180M-$914M-$7M
Total Liabilities & Equity$231M$310M$384M$267M$204M
— Key Metrics —
Total Debt$47M$64M$158M$150M$42M
Net Debt-$3M-$64M$72M$99M$7M
Total Investments$58M$33M$139M$10M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms